Policy

Members of Congress ask the FDA for documents relating to Aduhelm's controversial approval; outside experts will advise the FDA on booster shots; nursing shortages intensify.

A new Texas law ending abortions after 6 weeks takes effect, angering the American College of Obstetricians and Gynecologists; the CDC says mortality rates may not go back to normal until 2023; a Senate version of a bill aimed at lowering drug prices would only impact Medicare.

On this episode of Managed Care Cast, we speak with Ellen Kelsay, president and CEO of the Business Group on Health, on the findings from her organization's 2022 Large Employers’ Health Care Strategy and Plan Design Survey.

On this episode of Managed Care Cast, Laalitha Surapaneni, MD, MPH, an assistant professor of medicine at the University of Minnesota, describes her work in bringing awareness to the health impacts of climate change.

Pfizer's COVID-19 vaccine has gained full approval from the FDA.

Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.

President Joe Biden pushes back against governors banning school mask mandates; family behind Purdue Pharma refuses to pay settlement for opioid suit without legal protections; the Environmental Protection Agency (EPA) bans a pesticide linked to health issues in children.

Top US health officials outlined plans for rolling out COVID-19 booster shots to all American adults beginning in September, while CMS announced that nursing homes will be required to implement mandatory vaccinations for staff.

Recent research showed that patients with Medicaid are more likely than commercially insured patients to have worsened end-of-life experience and that Black patients with breast cancer fare worse than other ethnic groups when it comes COVID-19 outcomes.

President Joe Biden pushes for measures aimed at lowering drug prices; the Supreme Court allows a vaccine mandate imposed by Indiana University to stand; heat advisories issued for almost 200 million Americans.

The meeting comes a day after the FDA approved a third dose of a COVID-19 vaccine from Pfizer-BioNTech and Moderna in people who have received organ transplants or have other conditions that have damaged their immune systems.

This study provides the first evidence on how Marketplace insurers are altering their marketing in response to changes in competitive pressure over time.

Survey results underscore parents’ frustration with insurers when it comes to caring for their children with rare diseases.

The combined toll of the COVID-19 pandemic and the health effects of climate change tests an already beleaguered US health system.

FDA reportedly aims to fully approve Pfizer-BioNTech COVID-19 vaccine by early next month; Biogen’s Alzheimer drug sees little uptake; majority of Americans over 65 have received at least 1 dose of a COVID-19 vaccine.

Seventy percent of Americans have received at least 1 dose of a COVID-19 vaccine; CMS releases payment rules for fiscal year 2022; alcohol linked to over 700,000 new cancer diagnoses in 2020.

The study was conducted to shed more light on the growing issue of polypharmacy, an issue that is expected to increase as the US population ages.

Gary Lyman, MD, MPH, an oncologist and hematologist, discusses how financial incentives, concerns for patients, and interchangeability impact biosimilar prescribing patterns.

Drug optimization in older adults improved outcomes in this retrospective study.

A newly released internal CDC report shows the agency's communication struggles and its challenges in combatting the virulent delta variant, acknowledges the need for universal masking, and illustrates the effectiveness of vaccines in preventing more severe illness and death in those who are inoculated.

A new CMS rule increases reimbursement for providers; coffee is linked to decreased risk of arrhythmia; the Johnson & Johnson COVID-19 vaccine’s shelf life is extended.

When a New Zealand health care network switched to telehealth visits, its rheumatology patients had more health care interactions, but they had fewer changes in care and were less likely to be categorized as having active disease.

The designation means that pharmacists can switch patients to the less-expensive version of insulin without seeking approval from the clinician.

President Joe Biden requires federal workers to get vaccinated for COVID-19 or face strict safety protocols; Pfizer files federal lawsuit over reimbursing drugs through Medicare; and the CDC revises its testing guidance for fully vaccinated individuals.

Saying that in rare cases vaccinated people can spread COVID-19 due to the unique behavior of the delta variant, the CDC Tuesday recommended that vaccinated individuals revert to indoor mask wearing in hot-spot areas, including in schools this fall.